Canada
· Delayed Price · Currency is CAD MediPharm Labs Statistics
Total Valuation
MediPharm Labs has a market cap or net worth of CAD 28.78 million. The enterprise value is 16.34 million.
| Market Cap | 28.78M |
| Enterprise Value | 16.34M |
Important Dates
The last earnings date was Thursday, November 14, 2024.
| Earnings Date | Nov 14, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
MediPharm Labs has 411.12 million shares outstanding. The number of shares has increased by 29.04% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 411.12M |
| Shares Change (YoY) | +29.04% |
| Shares Change (QoQ) | +1.55% |
| Owned by Insiders (%) | 7.02% |
| Owned by Institutions (%) | 0.71% |
| Float | 382.24M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.75 |
| PB Ratio | 0.64 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -1.39 |
| EV / Sales | 0.42 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -6.41 |
Financial Position
The company has a current ratio of 3.21, with a Debt / Equity ratio of 0.01.
| Current Ratio | 3.21 |
| Quick Ratio | 1.84 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.26 |
| Interest Coverage | -9.37 |
Financial Efficiency
Return on equity (ROE) is -23.45% and return on invested capital (ROIC) is -7.41%.
| Return on Equity (ROE) | -23.45% |
| Return on Assets (ROA) | -6.20% |
| Return on Capital (ROIC) | -7.41% |
| Revenue Per Employee | 235,241 |
| Profits Per Employee | -70,813 |
| Employee Count | 166 |
| Asset Turnover | 0.63 |
| Inventory Turnover | 2.63 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | 0.88 |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 0.07 |
| 200-Day Moving Average | 0.07 |
| Relative Strength Index (RSI) | 48.00 |
| Average Volume (20 Days) | 264,768 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, MediPharm Labs had revenue of CAD 39.05 million and -11.76 million in losses. Loss per share was -0.03.
| Revenue | 39.05M |
| Gross Profit | 13.71M |
| Operating Income | -6.15M |
| Pretax Income | -12.03M |
| Net Income | -11.76M |
| EBITDA | -3.46M |
| EBIT | -6.15M |
| Loss Per Share | -0.03 |
Balance Sheet
The company has 13.09 million in cash and 654,000 in debt, giving a net cash position of 12.44 million or 0.03 per share.
| Cash & Cash Equivalents | 13.09M |
| Total Debt | 654,000 |
| Net Cash | 12.44M |
| Net Cash Per Share | 0.03 |
| Equity (Book Value) | 45.05M |
| Book Value Per Share | 0.11 |
| Working Capital | 23.81M |
Cash Flow
In the last 12 months, operating cash flow was -2.32 million and capital expenditures -229,000, giving a free cash flow of -2.55 million.
| Operating Cash Flow | -2.32M |
| Capital Expenditures | -229,000 |
| Free Cash Flow | -2.55M |
| FCF Per Share | -0.01 |
Margins
Gross margin is 35.11%, with operating and profit margins of -15.74% and -30.10%.
| Gross Margin | 35.11% |
| Operating Margin | -15.74% |
| Pretax Margin | -30.80% |
| Profit Margin | -30.10% |
| EBITDA Margin | -8.86% |
| EBIT Margin | -15.74% |
| FCF Margin | -6.53% |
Dividends & Yields
MediPharm Labs does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -29.04% |
| Shareholder Yield | -29.04% |
| Earnings Yield | -40.16% |
| FCF Yield | -8.86% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |